第2の薬剤との組み合わせにおいてリンホトキシンベータ受容体結合分子を使用する複合療法

Title:

第2の薬剤との組み合わせにおいてリンホトキシンベータ受容体結合分子を使用する複合療法

Document Type and Number:

Japanese Patent JP2009539999

Kind Code:

A

Abstract:

This invention features combination therapies that include a composition that activates lymphotoxin-beta receptor signaling in combination with one or more other biologic agents, as well as therapeutic methods.

More Like This:

JP4444493	Nucleic acid sequences encoding capsaicin receptors and capsaicin receptor-related polypeptides and their use
WO/2023/044465	HERV-K ANTIBODY THERAPEUTICS
JP5889912	Alaninyl Maytansinol antibody conjugate

Inventors:

Silverio, Erika Lorraine
Bottiglio, Cindy

Application Number:

JP2009515510A

Publication Date:

November 19, 2009

Filing Date:

June 15, 2007

Export Citation:

Click for automatic bibliography generation Help

Assignee:

Biogen Idec MA Inc.

International Classes:

A61K39/395; A61K31/506; A61K31/5377; A61K45/00; A61P35/00; A61P43/00; C07K16/28

Attorney, Agent or Firm:

Hidesaku Yamamoto
Takaaki Yasumura
Natsuki Morishita

Previous Patent: JP2009539998

Next Patent: 化学療法により誘導された貧血の治療のための化合物および方法